Author

Suprita Tawde

Research Scientist, Nexus Pharmaceuticals Inc. - Cited by 256 - Vaccines - Microparticles - Spray-drying

Biography

Dr. Suprita is an eminent researcher. Currently she is working at Research Scientist, Akorn Pharmaceuticals Inc., USA. She has many publications. Her area of expertise is Pharmacovigilance, Clinical Research, Pharmaceutical Management,  Regulatory Affairs,  Drug Safety .
Title
Cited by
Year
Particulate matter in injectables: main cause for recalls
SA TawdeJ. Pharmacovigil 3 (1), 1-2, 2014201
28
2014
Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin
L Chablani, SA Tawde, A Akalkotkar, MJ D’SouzaThe AAPS Journal 21, 1-11, 2019201
23
2019
Oral delivery of particulate prostate cancer vaccine: In vitro and in vivo evaluation
A Akalkotkar, SA Tawde, L Chablani, MJ D’SouzaJournal of drug targeting (4), 338-346, 121
20
2012
Development of a microparticulate prostate cancer vaccine and evaluating the effect of route of administration on its efficacy via the skin
A Akalkotkar, L Chablani, SA Tawde, C D’Souza, MJ D’SouzaJournal of microencapsulation 32 (3), 281-289, 202
15
2015
Generic Pharmaceuticals: is pharmacovigilance required
SA TawdeJ Pharmacovigil 2, 6, 2014201
11
2014
Nanotechnology in vaccine delivery
MJ D’souza, SA Tawde, A Akalkotkar, L Chablani, M D’souza, ...Molecular Vaccines: From Prophylaxis to Therapy-Volume 2, 727-741, 2014201
6
2014

Referred From: https://scholar.google.com/citations?user=83mO3FYAAAAJ&hl=en

Cited by
Citations 256
h-index 9
i10-index 9
Recommended Journals
Open Access Journals